Delivery Order SPE2DB22D1041-SPE2DB24FUAG8
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The order is for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S medication, with a potential value of $1,160.35 and a completion date of February 27, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp,...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $19,495.48, is for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S pharmaceutical products. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,811.99, is for the procurement of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product. The contract has an ultimate completion date of February 20, 2025 and utilizes a Firm Fixed Price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical wholesaler and distributor. The contract, valued at $10,287.51, is for the supply of the pharmaceutical product Amlod-Valsa-HCTZ 10-320-25 mg in 30-count packages. The delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,149.97, is for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of February 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,158.86 firm fixed-price contract is for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S medical supplies. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This is a $2,472.92 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a cardiovascular medication, and has an ultimate completion date of April 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,068.10 firm fixed price delivery order contract is for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a cardiovascular medication. The contract has an ultimate completion date of March 13, 2025. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,776.04, is for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a medical product, and has an ultimate completion date of November 20, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,897.80 firm fixed-price delivery order covers the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a medical product, with a completion date of December 26, 2023. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB24FUAG8Delivery Order
This is a firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,946.55, is for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, with a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 3/14/24 |